Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001513162-17-000183

President & CEO bought 10,000 shares at an average $0.88 ($8,797)

From the SEC's structured data for this filing

Trades in this filing

BERMAN ROBERT ANDREW · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-06-02 Purchase : show line 1 in the form +100 $0.85 $85 51,653 D
2017-06-02 Purchase : show line 2 in the form +9,900 $0.88 $8,712 61,553 D
Open-market purchases · 10,000 sh · avg $0.88 · $8,797
Loading xslF345X03/primary_doc.xml…